National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

AEG35156
A second-generation synthetic antisense oligonucleotide with potential antineoplastic activity. AEG35156 selectively blocks the cellular expression of X-linked inhibitor of apoptosis protein (XIAP), a pivotal inhibitor of apoptosis that is overexpressed in many tumors. This agent reduces total levels of XIAP in tumor cells, working synergistically with cytotoxic drugs to overcome tumor cell resistance to apoptosis. XIAP interferes with both the intrinsic and extrinsic program-death signaling pathways, which may render tumor cells resistant to apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:GEM640

Previous:Adriamycin PFS, Adriamycin RDF, Adrucil, ADVEXIN, AEE788
Next:Aeroseb-Dex, Aeroseb-HC, aerosol sargramostim, aerosolized liposomal 9-nitro-20 (S) camptothecin, Affinitac